QVIDTVM Management LLC Has $34.67 Million Stock Holdings in Solventum Co. (NYSE:SOLV)

QVIDTVM Management LLC lifted its holdings in shares of Solventum Co. (NYSE:SOLV) by 13.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 497,276 shares of the company’s stock after purchasing an additional 59,059 shares during the quarter. Solventum accounts for 24.3% of QVIDTVM Management LLC’s holdings, making the stock its 2nd largest position. QVIDTVM Management LLC owned 0.29% of Solventum worth $34,670,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Deseret Mutual Benefit Administrators bought a new stake in Solventum during the second quarter worth about $25,000. Hollencrest Capital Management bought a new stake in shares of Solventum during the 2nd quarter worth approximately $25,000. Partnership Wealth Management LLC acquired a new stake in shares of Solventum during the 2nd quarter worth approximately $26,000. Richard W. Paul & Associates LLC bought a new position in Solventum in the second quarter valued at approximately $26,000. Finally, Family Firm Inc. acquired a new position in Solventum during the second quarter valued at approximately $26,000.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on SOLV shares. BTIG Research assumed coverage on Solventum in a research report on Thursday, September 5th. They issued a “neutral” rating on the stock. Piper Sandler upped their price objective on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Morgan Stanley increased their price objective on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Stifel Nicolaus started coverage on shares of Solventum in a research note on Tuesday, October 8th. They set a “buy” rating and a $82.00 target price on the stock. Finally, The Goldman Sachs Group increased their price target on Solventum from $48.00 to $54.00 and gave the company a “sell” rating in a research note on Monday, August 12th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $68.00.

Solventum Trading Up 1.1 %

Shares of NYSE SOLV opened at $71.58 on Tuesday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The firm has a fifty day simple moving average of $70.52 and a 200 day simple moving average of $62.35. Solventum Co. has a twelve month low of $47.16 and a twelve month high of $96.05.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.